Lyterian Therapeutics derives its name from the Greek word λυτήριος or lutḗrios, that defines the termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. We are inspired to learn from the logic that orchestrates homeostatic equilibria and fosters healing in response to disease. At Lyterian Therapeutics, we are committed to developing medicines for patients in need by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically validated targets.
View Top Employees from Lyterian TherapeuticsWebsite | https://lyterian.com |
Employees | 32 (14 on RocketReach) |
Founded | 2022 |
Address | 630 Gateway Blvd, South San Francisco, California 94080, US |
Industry | Biotechnology Research |
Looking for a particular Lyterian Therapeutics employee's phone or email?
Daniel Bettis is the Director of Facilities of Lyterian Therapeutics.
14 people are employed at Lyterian Therapeutics.
Lyterian Therapeutics is based in South San Francisco, California.